Corium
Yuemei (Meg) C. has extensive work experience in the medical field. Yuemei (Meg) currently serves as the Vice President and Head of Medical at Corium. Prior to that, they held the position of Vice President of Medical Affairs at Centrexion Therapeutics Corp. Yuemei (Meg) also worked as the Medical Director and Therapeutic Area Head, Medical Strategies and Scientific Affairs at LEO Pharma. Before that, they were the Sr Director and Head of Global Professional Strategy at AbbVie, and the National Director and Head of Field Medical at Bristol Myers Squibb. Yuemei (Meg) also served as the Senior Director and Head of Medical & Scientific Affairs & Strategic Business at Solstice Neurosciences, and as a Manager, Sr. Manager, Regional Medical Director at Allergan. Earlier in their career, they were an NIH National Research Service Award Fellow and a Faculty member at the University of Pennsylvania School of Medicine.
Yuemei (Meg) C. has a Ph.D. in Biology/Immunology from The University of New Mexico. Additionally, they have completed an executive leadership program at The Wharton School. No specific start or end years were provided for either educational experience.
This person is not in any offices
Corium
Corium is a commercial-stage biopharmaceutical company that is leading the development and commercialization of central nervous system (CNS) healthcare therapies that provide clinicians with important treatment options for patients, their families, and their caregivers. Collaborating with some of the world's largest pharmaceutical and consumer product companies, we have a track record and depth of experience in taking products from concept, through development, to manufacturing and final commercialization.